Showing results (101-110 of 224) with videos related to
Sort By:
Pageof 23
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|April 23, 1979
Lymphocyte proliferation to phytohemagglutinin (PHA) in hepatitis B antigen-positive and -negative hepatitisC P Sodomann, M Rother, K Havemann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" techniqueM Behn, S Qun, W Pankow, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1993
Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancerU Kaiser, C Schardt, D Brandscheidt, et al.Biological Chemistry Hoppe-Seyler|November 1, 1991
Protein C degradation in vitro by neutrophil elastaseI Eckle, R Seitz, R Egbring, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological typesC Schardt, J Heymanns, C Schardt, et al.The Journal of Clinical Investigation|April 1, 1978
Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitroM Gramse, C Bingenheimer, W Schmidt, et al.Onkologie|October 1, 1986
[Analysis of the effect of selection in a therapy study]H Bülzebruck, R Holle, K Havemann, et al.European Journal of Biochemistry|July 1, 1982
Purification by affinity chromatography of 2,4-dienoyl-CoA reductases from bovine liver and Escherichia coliV Dommes, W Luster, M Cvetanović, et al.British Journal of Cancer|June 1, 1991
Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survivalM Wolf, R Holle, K Hans, et al.Annals of Hematology|September 1, 1996
Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myelomaU Kaiser, M Oldenburg, G Jaques, et al.Pageof 23